Browse > Article

Fermented Soybean Powder Reduces Body Weight Gain and Improves Hepatic Lipid Accumulation in High Fat Diet-Fed Obese Male C57BL/6N Mice  

Tsung, Pei-Chin (Dept. of Formula Science, College of Oriental Medicine & Research Institute of Oriental Medicine, Dong-Eui University)
Lee, Hee-Young (Dept. of Formula Science, College of Oriental Medicine & Research Institute of Oriental Medicine, Dong-Eui University)
Lee, Hye-Rim (Dept. of Formula Science, College of Oriental Medicine & Research Institute of Oriental Medicine, Dong-Eui University)
Jeong, Hae-Gyeong (Dept. of Formula Science, College of Oriental Medicine & Research Institute of Oriental Medicine, Dong-Eui University)
Yin, Yuan-Mi (Dept. of Social Welfare, College of Social Science, Dong-Guk University)
Yoon, Mi-Chung (Dept. of Life Sciences, Mok-Won University)
Park, Sun-Dong (Dept. of Formula Science, College of Oriental Medicine, Dong-Guk University)
Shin, Soon-Shik (Dept. of Formula Science, College of Oriental Medicine & Research Institute of Oriental Medicine, Dong-Eui University)
Publication Information
Herbal Formula Science / v.18, no.2, 2010 , pp. 201-213 More about this Journal
Abstract
Objectives : We investigated the effects of fermented soybean(FSOB) on body weight and examined whether hepatic lipid accumulation are inhibited by it in high fat diet-fed obese male mice. Methods : 8 weeks old, high fat diet-fed obese male mice were divided into 5 groups: C57BL/6N normal, control, FSOB(1), (2) and (3). After mice were treated with FSOB for 9 weeks, we measured body weight gain, food intake, feeding efficiency ratio, fat weight, plasma leptin and lipid levels. We also did histological analysis for liver and fat on the mice. Results : 1. Compared with controls, FSOB-treated mice had lower body weight gain and adipose tissue weight, the magnitudes of which were prominent in FSOB(3) and FSOB(1). 2. Compared with controls, FSOB-treated mice had lower feeding efficiency ratio and blood plasma leptin levels, the magnitude of which was prominent in FSOB(3). 3. Compared with controls, FSOB-treated mice had lower blood plasma total cholesterol and LDL-cholesterol levels. 4. Blood plasma AST and ALT concentrations were not changed by FSOB, indicating FSOB do not show any toxic effects. 5. Consistent with their effects on body weight gain, the size of adipocytes were significantly decreased by FSOB, whereas the adipocyte number per unit area was significantly increased, suggesting that FSOB decreased the number of large adipocytes. Hepatic lipid accumulation was decreased by FSOB. Conclusions : These results demonstrate that FSOB effectively reduces body weight gain, feeding efficiency ratio, blood plasma leptin level and improves hepatic lipid accumulation.
Keywords
fermented soybean; body weight gain; hepatic lipid accumulation;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Lee CH, Yang L, Xu JZ, Yeung SYV, Huang Y, Chen ZY. Relative antioxidant activity of soybean isoflavones and their glycosides. Food Chemistry. 2005;90:735-41.   DOI   ScienceOn
2 Friis-Liby I, Aldenborg F, Jerlstad P, Rundströom K, Bjöornsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol. 2004;39(9): 864-9.   DOI   ScienceOn
3 박찬성, 김동한, 김미림, 석장미, 김미려. 한방 초콩환이 고지방식이를 급여한 흰쥐의 체중 및 지질변화에 미치는 영향. 大韓本草學會誌. 2007;22(4):127-35.   과학기술학회마을
4 김지영, 정은정, 문숙희, 박건영. 3T3-L1 지방 세포에서 Bacillus subtilis KC-3 발효두유의 항 비만 효과. 한국식품영양과학회지. 2010;39(8): 1126-31.
5 Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5): 450-5.   DOI   ScienceOn
6 오창호. 비만억제자인 $\alpha$-MSH 유사체의 합성 및 약효분석 (신약개발연구개발사업 최종보고서). 서울:보건복지부. 2003:21.
7 Garrido-Polonio C, Garcia-Linares MC, Garcia -Arias MT, Lopez-Varela S, Garcia-Fernandez MC, Terpstra AH, Sanchez-Muniz FJ.. Thermally oxidised sunflower-seed oil increases liver and serum peroxidation and modifies lipoprotein composition in rats. Br J Nutr. 2004 Aug; 92(2):257-65.   DOI   ScienceOn
8 Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: An agenda for clinical research. Hepatology. 2002;35(4):746-52.   DOI   ScienceOn
9 Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995; 22(6):1714-9.   DOI
10 Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):138-43.   DOI   ScienceOn
11 Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221-31.   DOI   ScienceOn
12 Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm Res. 2003;52:341-6.   DOI   ScienceOn
13 Brouns F. Soya isoflavones: a new and promising ingredient for the health foods sector. Food Research International. 2002;35:187-93.   DOI   ScienceOn
14 Shon DH. Nutritional and bioactive components of soymilk and cow's milk (a review). Korea Soybean Digest. 1997;14:66-76.
15 Lee SY, Bae YJ, Lee SY, Choi MK, Choe SH, Sung CJ. The effect of soy isoflavone on sex hormone status and premenstrual syndrome in female college students. Korean J Nutr. 2005; 38:203-10.   과학기술학회마을
16 Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein, daidzein and their $\beta$-glycoside conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem. 1993;41:1961-7.   DOI   ScienceOn
17 國家中醫藥管理局 中華本草 編委會編. 中華本 草 (4冊). 第1版第1次印刷. 上海:上海科學技術 出版社. 1999:487-9.
18 Lee KA, Jang JO, Yoon HK, Kim MS. Antithrombotic activities of Cheongkookjang and Cheongkookjang fermented with green tea or mugwort. Korean J Microbiol. 2007;43:298-303.   과학기술학회마을
19 Watanabe S, Haba R, Terashima K, Arai Y, Miura T, Chiba D, Takamatsu M. Antioxidant activity of soya hypocotyl tea in humans. Biofactors. 2000;12:227-32.   DOI   ScienceOn